Immunis Publishes Research Study Showing Reversal of Aged Muscle Deficits

IRVINE, Calif., Aug. 15, 2022 /PRNewswire/ — Immunis Inc., a private biotechnology company developing a novel treatment for age and disease-related immune decline, announced the peer-reviewed publication in GeroScience of research conducted by Professor Micah Drummond at the University…